Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2010 1
2011 1
2012 2
2013 2
2014 2
2015 3
2016 4
2018 4
2019 1
2020 2
2021 5
2022 1
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
The change from baseline in the CDR-SB score at week 116 was 3.35 with gantenerumab and 3.65 with placebo in the GRADUATE I trial (difference, -0.31; 95% confidence interval [CI], -0.66 to 0.05; P = 0.10) and was 2.82 with gantenerumab and 3.01 with placebo in the GRADUATE …
The change from baseline in the CDR-SB score at week 116 was 3.35 with gantenerumab and 3.65 with placebo in the GRADUATE I trial (differenc …
ABO blood types and sepsis mortality.
Itenov TS, Sessler DI, Khanna AK, Ostrowski SR, Johansson PI, Erikstrup C, Pedersen OB, Rygård SL, Holst LB, Bestle MH, Hein L, Lindhardt A, Tousi H, Andersen MH, Mohr T, Lundgren JD, Jensen JU. Itenov TS, et al. Ann Intensive Care. 2021 Apr 20;11(1):61. doi: 10.1186/s13613-021-00844-2. Ann Intensive Care. 2021. PMID: 33877463 Free PMC article.
In a pooled analysis blood type B carried a slightly lower risk of 30-day all-cause mortality compared to non-blood type B (adjusted HR 0.88; 95%-CI 0.79-0.98; p = 0.02). There was no difference in the risk of AKI. Soluble thrombomodulin and syndecan-1 concentrations were …
In a pooled analysis blood type B carried a slightly lower risk of 30-day all-cause mortality compared to non-blood type B (adjusted HR 0.88 …
Dietary choline and betaine intake, cardio-metabolic risk factors and prevalence of metabolic syndrome among overweight and obese adults.
Abbasi MSP, Tousi AZ, Yazdani Y, Vahdat S, Gharebakhshi F, Nikrad N, Manzouri A, Ardekani AM, Jafarzadeh F. Abbasi MSP, et al. BMC Endocr Disord. 2023 Mar 27;23(1):67. doi: 10.1186/s12902-023-01323-4. BMC Endocr Disord. 2023. PMID: 36973700 Free PMC article.

RESULTS: Higher body mass index (BMI), waist to hip ratio (WHR), fat-free mass (FFM) and basal metabolic rate (BMR) were observed in higher tertiles of dietary choline intake (P < 0.01). There was no significant difference in terms of biochemical parameters among differ

…
RESULTS: Higher body mass index (BMI), waist to hip ratio (WHR), fat-free mass (FFM) and basal metabolic rate (BMR) were observed in higher …
Antibiotic prescriptions among dentists across Norway and the impact of COVID-19 pandemic.
Tousi F, Al Haroni M, Lie SA, Lund B. Tousi F, et al. BMC Oral Health. 2023 Sep 8;23(1):649. doi: 10.1186/s12903-023-03380-6. BMC Oral Health. 2023. PMID: 37684614 Free PMC article.

An overall decrease in the number of prescriptions by health professions other than dentists during the 5 years (IRR = 0.92, 95% CI:0.92-0.93, p < 0.001) was observed. For dentists a slight increase in the number of prescriptions (IRR = 1.01, 95% CI: 1.01-1.01, p

…
An overall decrease in the number of prescriptions by health professions other than dentists during the 5 years (IRR = 0.92, 95% CI:0.92-0.9 …
SALL4 as a new biomarker for early colorectal cancers.
Ardalan Khales S, Abbaszadegan MR, Abdollahi A, Raeisossadati R, Tousi MF, Forghanifard MM. Ardalan Khales S, et al. J Cancer Res Clin Oncol. 2015 Feb;141(2):229-35. doi: 10.1007/s00432-014-1808-y. Epub 2014 Aug 26. J Cancer Res Clin Oncol. 2015. PMID: 25156818
RESULTS: The blood copy number of SALL4 in recruited CRC patients was significantly higher than healthy controls (p = 0.0001). This high copy number was not only inversely associated with the depth of tumor invasion (p = 0.045), but also was significantly correlated …
RESULTS: The blood copy number of SALL4 in recruited CRC patients was significantly higher than healthy controls (p = 0.0001). This h …
Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies.
Pillai JA, Wu G, Tousi B, Larvie M, Léger GC, Leverenz JB. Pillai JA, et al. Parkinsonism Relat Disord. 2019 Jul;64:300-303. doi: 10.1016/j.parkreldis.2019.03.005. Epub 2019 Mar 15. Parkinsonism Relat Disord. 2019. PMID: 30905401 Free PMC article.
RESULTS: Significant overlap between DLB and AD patients (occipital, parietal, temporal and frontal hypometabolism) and between DLB and FTD (frontal hypometabolism and the posterior cingulate sign) were identified. Right amygdala (p = 0.028) and right posterior cingulate ( …
RESULTS: Significant overlap between DLB and AD patients (occipital, parietal, temporal and frontal hypometabolism) and between DLB and FTD …
Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia.
Matthews DC, Ritter A, Thomas RG, Andrews RD, Lukic AS, Revta C, Kinney JW, Tousi B, Leverenz JB, Fillit H, Zhong K, Feldman HH, Cummings J. Matthews DC, et al. Alzheimers Dement (N Y). 2021 Feb 14;7(1):e12106. doi: 10.1002/trc2.12106. eCollection 2021. Alzheimers Dement (N Y). 2021. PMID: 33614888 Free PMC article.

The study met its primary end point, demonstrating favorable change in FDG-PET differences in rasagiline versus placebo in middle frontal (P < 0.025), anterior cingulate (P < 0.041), and striatal (P < 0.023) regions. Clinical measures showed benefit

…
The study met its primary end point, demonstrating favorable change in FDG-PET differences in rasagiline versus placebo in middle frontal ( …
Dietary carbohydrate quality index (CQI), cardio-metabolic risk factors and insulin resistance among adults with obesity.
Nikrad N, Hosseini B, Pakmehr A, Tousi AZ, Ardekani AM, Farhangi MA, Akhavan-Sigari R. Nikrad N, et al. BMC Endocr Disord. 2023 Aug 11;23(1):171. doi: 10.1186/s12902-023-01420-4. BMC Endocr Disord. 2023. PMID: 37568117 Free PMC article.
RESULTS: Subjects in the third quartile of CQI had significantly lower systolic blood pressure (SBP) (P = 0.03) and diastolic blood pressure (DBP) (P = 0.01). Participants in the higher quartiles of CQI had more intake of energy, carbohydrates, fat, saturated fatty …
RESULTS: Subjects in the third quartile of CQI had significantly lower systolic blood pressure (SBP) (P = 0.03) and diastolic blood p …
Color Vision Impairment Differentiates Alzheimer Dementia From Dementia With Lewy Bodies.
Flanigan PM, Khosravi MA, Leverenz JB, Tousi B. Flanigan PM, et al. J Geriatr Psychiatry Neurol. 2018 Mar;31(2):97-102. doi: 10.1177/0891988718767579. J Geriatr Psychiatry Neurol. 2018. PMID: 29658429

New-onset CVI prevalence differed significantly based on diagnosis: patients with pro-AD (20%), patients with AD (15%), patients with pro-DLB (38%), and patients with DLB (78%, P < .001). In a stepwise multivariate logistic regression analysis to determine factors assoc

…
New-onset CVI prevalence differed significantly based on diagnosis: patients with pro-AD (20%), patients with AD (15%), patients with pro-DL …
38 results